Fiduciary Trust CO Gilead Sciences, Inc. Transaction History

Fiduciary Trust CO

  • $6.5 Billion
  • Q2 2024

A detailed history of Fiduciary Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 10,617 shares of GILD stock, worth $891,297. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,617
Previous 14,688 27.72%
Holding current value
$891,297
Previous $1.08 Million 32.28%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$63.15 - $72.88 $257,083 - $296,694
-4,071 Reduced 27.72%
10,617 $728,000
Q1 2024

May 13, 2024
SELL
$71.58 - $87.29 $29,848 - $36,399
-417 Reduced 2.76%
14,688 $1.08 Million
Q4 2023

Feb 12, 2024
SELL
$73.27 - $83.09 $54,439 - $61,735
-743 Reduced 4.69%
15,105 $1.22 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $53,976 - $58,889
730 Added 4.83%
15,848 $1.19 Million
Q2 2023

Aug 01, 2023
SELL
$76.01 - $86.7 $94,784 - $108,114
-1,247 Reduced 7.62%
15,118 $1.17 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $22,419 - $25,543
-290 Reduced 1.74%
16,365 $1.36 Million
Q4 2022

Feb 13, 2023
SELL
$62.32 - $89.47 $23,930 - $34,356
-384 Reduced 2.25%
16,655 $1.43 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $7,144 - $8,161
-120 Reduced 0.7%
17,039 $1.05 Million
Q2 2022

Aug 12, 2022
SELL
$57.72 - $65.01 $26,435 - $29,774
-458 Reduced 2.6%
17,159 $1.06 Million
Q1 2022

May 12, 2022
SELL
$57.92 - $72.58 $16,217 - $20,322
-280 Reduced 1.56%
17,617 $1.05 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $36,527 - $41,459
-563 Reduced 3.05%
17,897 $1.3 Million
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $66,742 - $72,007
-986 Reduced 5.07%
18,460 $1.29 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $80,479 - $87,935
-1,268 Reduced 6.12%
19,446 $1.34 Million
Q1 2021

May 19, 2021
BUY
$60.0 - $68.46 $17,100 - $19,511
285 Added 1.4%
20,714 $1.34 Million
Q4 2020

Jan 26, 2021
SELL
$56.65 - $64.55 $688,127 - $784,088
-12,147 Reduced 37.29%
20,429 $1.19 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $68,558 - $86,200
-1,104 Reduced 3.28%
32,576 $2.06 Million
Q2 2020

Aug 13, 2020
BUY
$72.34 - $84.0 $73,497 - $85,344
1,016 Added 3.11%
33,680 $2.59 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $148,746 - $190,522
-2,375 Reduced 6.78%
32,664 $2.44 Million
Q4 2019

Feb 04, 2020
SELL
$61.62 - $67.78 $249,869 - $274,847
-4,055 Reduced 10.37%
35,039 $2.28 Million
Q3 2019

Nov 12, 2019
SELL
$62.51 - $69.0 $210,283 - $232,116
-3,364 Reduced 7.92%
39,094 $2.48 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $237,209 - $266,002
-3,834 Reduced 8.28%
42,458 $2.87 Million
Q1 2019

May 07, 2019
SELL
$62.53 - $70.05 $649,999 - $728,169
-10,395 Reduced 18.34%
46,292 $3.01 Million
Q4 2018

Jan 29, 2019
SELL
$60.54 - $79.0 $1.52 Million - $1.98 Million
-25,025 Reduced 30.63%
56,687 $3.55 Million
Q3 2018

Nov 13, 2018
SELL
$71.28 - $78.92 $301,086 - $333,358
-4,224 Reduced 4.92%
81,712 $6.31 Million
Q2 2018

Aug 03, 2018
SELL
$64.88 - $75.68 $363,068 - $423,505
-5,596 Reduced 6.11%
85,936 $6.09 Million
Q1 2018

May 08, 2018
SELL
$72.84 - $88.8 $710,481 - $866,155
-9,754 Reduced 9.63%
91,532 $6.9 Million
Q4 2017

Jan 29, 2018
SELL
$71.15 - $83.52 $1.18 Million - $1.38 Million
-16,525 Reduced 14.03%
101,286 $7.26 Million
Q3 2017

Nov 02, 2017
BUY
$72.11 - $85.47 $8.5 Million - $10.1 Million
117,811
117,811 $9.55 Million

Others Institutions Holding GILD

# of Institutions
1,878
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email